SCHEDULE: Park Ha Biological Technology Stakeholder Update

Peverel Summit Holdings Limited and Qi Meng report a combined 9.8% beneficial ownership of Park Ha Biological Technology's Class A Ordinary Shares.

Summary

• Peverel Summit Holdings Limited and Qi Meng have jointly reported their beneficial ownership of Park Ha Biological Technology Co., Ltd. Class A Ordinary Shares.
• The total beneficial ownership reported is 422,500 shares, representing 9.8% of the class.
• This ownership includes 260,000 shares for which warrants are exercisable within the next 60 days.
• The calculation of outstanding shares is based on 2,297,902 shares post-reverse stock split effective August 6, 2026, plus 2,000,000 shares underlying exercisable warrants.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as neutral to slightly negative, as it primarily reports a change in beneficial ownership without disclosing new strategic information or financial performance.

Positives

• The filing clearly outlines the beneficial ownership stake held by Peverel Summit Holdings Limited and Qi Meng.
• The reporting is based on a specific and defined share count, including exercisable warrants.

Negatives

• The filing does not provide any new financial performance data or strategic updates for Park Ha Biological Technology.
• The information is purely a disclosure of ownership, offering no insight into the company's operational health or future prospects.

Risks

• The filing does not explicitly mention any risks associated with the company's operations or financial status.

Future Outlook

No forward-looking statements or guidance are provided in this filing; it is a disclosure of current ownership.

Management Comments

• The filing includes a certification stating that the securities were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer, nor in connection with any transaction having that purpose or effect, other than in connection with a nomination under Rule 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard disclosures for significant beneficial ownership changes and do not typically contain operational or financial insights. This filing indicates a substantial stake by Peverel Summit Holdings Limited and Qi Meng in Park Ha Biological Technology.

Stakeholder Impact

• Shareholders may note the significant stake held by Peverel Summit Holdings Limited and Qi Meng, which could influence future corporate actions or governance discussions.

Key Dates

Keywords

Beneficial Ownership, Park Ha Biological Technology, Peverel Summit Holdings, Qi Meng, Class A Ordinary Shares, Schedule 13G, Warrants